AKT2 and lip and oral cavity carcinoma: In pursuit of candidate/lead molecules for oral cancer, it is hypothesized that chemical entities inhibiting the overexpression of Akt1 and Akt2 without suppressing the expression of MAOB may demonstrate promising therapeutic potential.